Table 3.
Transcript | PLGS score | Peptide | % Seq. | |
---|---|---|---|---|
name | score | matches | coverage | Group |
SVMPIII-1 | 896.04 | 29 | 57.84 | 1 |
SVMPIII-2b | 2,805.59 | 26 | 62.77 | 2 |
SVMPIII-2a | 2,694.91 | 29 | 66.50 | 3 |
SVMPIII-4a | 900.64 | 29 | 64.92 | 3 |
SVMPIII-4b | 890.08 | 30 | 64.92 | 3 |
CRISP-1b | 6,457.39 | 23 | 93.67 | 4 |
CRISP-1d | 6,198.10 | 21 | 85.52 | 4 |
CRISP-1a | 6,248.59 | 21 | 87.33 | 5 |
CRISP-1c | 6,507.89 | 23 | 95.48 | 5 |
NatA-10 | 327.40 | 5 | 7.92 | 6 |
3FTx-1a | 4,423.76 | 10 | 78.89 | 7 |
3FTx-1b | 6,549.43 | 10 | 78.89 | 7 |
3FTx-1c | 4,423.76 | 10 | 78.89 | 7 |
3FTx-1d | 6,549.43 | 10 | 78.89 | 7 |
3FTx-1e | 6,549.43 | 10 | 78.89 | 7 |
3FTx-1f | 4,423.76 | 8 | 74.44 | 7 |
3FTx-3a | 8,140.22 | 6 | 40.22 | 8 |
3FTx-3b | 8,140.22 | 6 | 40.22 | 8 |
3FTx-3c | 8,140.22 | 6 | 40.22 | 8 |
3FTx-3d | 2,067.74 | 4 | 20.65 | 8 |
3FTx-3e | 8,140.22 | 6 | 40.22 | 8 |
3FTx-3f | 8,140.22 | 6 | 40.22 | 8 |
3FTx-3g | 8,140.22 | 6 | 40.22 | 8 |
3FTx-3h | 8,140.22 | 6 | 40.22 | 8 |
3FTx-3i | 8,140.22 | 6 | 40.22 | 8 |
3FTx-3j | 6,072.48 | 2 | 19.78 | 8 |
3FTx-3k | 2,067.74 | 4 | 20.65 | 8 |
3FTx-4a | 7,234.41 | 15 | 100.00 | 9 |
3FTx-4b | 6,945.58 | 13 | 87.21 | 9 |
3FTx-4c | 5,137.73 | 14 | 94.19 | 9 |
3FTx-4d | 7,234.41 | 14 | 92.94 | 9 |
3FTx-5 | 480.09 | 2 | 53.97 | 10 |
3FTx-6b | 480.09 | 2 | 53.97 | 10 |
3FTx-6a | 1,252.34 | 3 | 53.97 | 11 |
3FTx-6c | 1,252.34 | 3 | 54.84 | 11 |
3FTx-7a | 6,785.76 | 11 | 66.67 | 12 |
3FTx-7b | 6,815.80 | 12 | 78.89 | 12 |
3FTx-7c | 6,785.76 | 11 | 66.67 | 12 |
3FTx-7d | 2,506.53 | 8 | 62.22 | 12 |
3FTx-8a | 3,911.73 | 9 | 51.11 | 13 |
3FTx-8b | 3,911.73 | 9 | 51.11 | 13 |
3FTx-8c | 3,911.73 | 9 | 51.11 | 13 |
3FTx-8d | 3,911.73 | 9 | 51.11 | 13 |
3FTx-8e | 3,911.73 | 9 | 51.11 | 13 |
3FTx-8f | 3,911.73 | 8 | 39.33 | 13 |
3FTx-9a | 9,625.12 | 14 | 81.40 | 14 |
3FTx-9b | 9,625.12 | 14 | 81.40 | 14 |
3FTx-9c | 9,625.12 | 14 | 81.40 | 14 |
3FTx-9d | 9,625.12 | 14 | 81.40 | 14 |
3FTx-9e | 9,625.12 | 13 | 69.41 | 14 |
3FTx-9f | 9,625.12 | 13 | 69.41 | 14 |
3FTx-9g | 9,625.12 | 14 | 81.40 | 14 |
3FTx-10a | 3,753.53 | 10 | 75.58 | 15 |
3FTx-10b | 4,914.06 | 13 | 91.86 | 15 |
3FTx-10c | 3,753.53 | 10 | 79.27 | 15 |
3FTx-10d | 4,914.06 | 12 | 84.71 | 15 |
3FTx-10e | 4,914.06 | 12 | 84.71 | 15 |
3FTx-10f | 3,530.34 | 10 | 69.77 | 15 |
3FTx-10g | 4,914.06 | 13 | 91.86 | 15 |
3FTx-10h | 4,914.06 | 13 | 91.86 | 15 |
3FTx-10i | 4,914.06 | 13 | 76.85 | 15 |
3FTx-2a | 6,549.43 | 9 | 55.56 | – |
3FTx-2b | 6,549.43 | 9 | 55.56 | – |
3FTx-2c | 6,549.43 | 9 | 55.56 | – |
3FTx-2d | 4,423.76 | 9 | 55.56 | – |
3FTx-2e | 6,549.43 | 9 | 55.56 | – |
3FTx-2f | 5,175.20 | 6 | 34.44 | – |
3FTx-2g | 3,049.53 | 6 | 34.44 | – |
Transcripts were grouped on the basis of shared, unique peptides. Identifications without a group designation lacked unique identifying peptides but still had peptide matches. Abbreviations: 3FTx–three-finger toxin, CRISP–cysteine-rich secretory protein, SVMPIII–snake venom metalloproteinase (P-III).